✦ LIBER ✦

Novel cancer suppressor gene for esophageal cancer: manganese superoxide dismutase

✍ Scribed by G.-G. Sun; Y.-D. Wang; L.-Q. Chen; S.-J. Wang; G.-L. Liu; X.-R. Yu; Y.-J. Cheng; Q. Liu

Book ID: 108982392
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 583 KB
Volume: 24
Category: Article
ISSN: 1120-8694
DOI: 10.1111/j.1442-2050.2010.01149.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of manganese superoxide dismu

Expression of manganese superoxide dismutase in esophageal and gastric cancers

✍ Ryo Izutani; Satoshi Asano; Motohiro Imano; Daisuke Kuroda; Michio Kato; Harumas 📂 Article 📅 1998 🏛 Springer Japan 🌐 English ⚖ 549 KB

Manganese superoxide dismutase gene poly

Manganese superoxide dismutase gene polymorphism, MnSOD plasma levels and risk of epithelial ovarian cancer

✍ Altay Burak Dalan; Arzu Ergen; Hülya Yılmaz; Ateş Karateke; Turgay İsbir 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

RelB regulates manganese superoxide dism

RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells

✍ Josson, S; Xu, Y; Fang, F; Dhar, S K; St Clair, D K; St Clair, W H 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 288 KB

Polymorphism in the manganese superoxide

Polymorphism in the manganese superoxide dismutase (MnSOD) gene and risk of breast cancer in young women

✍ Malin Bergman; Marie Ahnström; Pia Palmebäck Wegman; Sten Wingren 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 214 KB

Mutations in the promoter reveal a cause

Mutations in the promoter reveal a cause for the reduced expression of the human manganese superoxide dismutase gene in cancer cells

✍ Xu, Yong; Krishnan, Anuradha; Wan, X Steven; Majima, Hideyuki; Yeh, Che-Chung; L 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 672 KB

Upregulation of manganese superoxide dis

Upregulation of manganese superoxide dismutase (SOD2) is a common pathway for neuroendocrine differentiation in prostate cancer cells

✍ Isabel Quirós; Rosa M. Sáinz; David Hevia; Olivia García-Suárez; Aurora Astudill 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 323 KB

## Abstract Despite improvements in diagnosis of advanced prostate cancer (PCa), treatment is not efficient and 5‐year survival is still low. Initially, the less abundant of cell types, neuroendocrine cells (NE), are involved in regulatory process but their physiological role is not fully understoo